Blood-testing startup Theranos on Friday announced it will lay off 155 employees – about 41 percent of its workforce – the latest blow to hit the company facing multiple lawsuits, sanctions and other regulatory issues. The company said the move is part of its ongoing restructuring as it shifts focus to the commercialization of its miniLab testing platform.